Panoptosis – new frontier in research in head neck cancer
Head and neck squamous cell carcinoma (HNSCC) is a common cancer that can develop resistance to therapeutic approaches, including chemotherapy, targeted therapy, and immunotherapy. PANoptosis, a non-apoptotic cell death mechanism, has been identified as a potential solution. PANoptosis is a highly c...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Oral Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024001560 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553761566195712 |
|---|---|
| author | Shrikant B. Mali |
| author_facet | Shrikant B. Mali |
| author_sort | Shrikant B. Mali |
| collection | DOAJ |
| description | Head and neck squamous cell carcinoma (HNSCC) is a common cancer that can develop resistance to therapeutic approaches, including chemotherapy, targeted therapy, and immunotherapy. PANoptosis, a non-apoptotic cell death mechanism, has been identified as a potential solution. PANoptosis is a highly coordinated and dynamically balanced programmed inflammatory cell death pathway that combines the main features of pyroptosis, apoptosis, and necroptosis. It has been linked to the development of multiple systemic diseases in the human body, including infectious diseases, cancer, neurodegenerative diseases, and inflammatory diseases. The innate immune system provides the first line of defense against cellular perturbations, and inflammatory programmed cell death is elicited in response to microbial infections or alterations in cellular homeostasis. Programmed cell death (PCD) is a key mechanism for studying anticancer drugs and has a significant impact on the development and management of cancer. Recent research has revealed the existence of the distinct inflammatory PCD modality known as PANoptosis, which is controlled by complex PANoptosome complexes built by combining elements from different PCD pathways. No single PCD route is sufficient to explain all of the physiologic effects seen in PANoptosis. Numerous studies have demonstrated that PANoptosis can successfully stop cancer cells from growing, proliferating, and developing drug resistance, changing the focus of targeted anticancer therapy. |
| format | Article |
| id | doaj-art-ac8645d7b77c4a01b64d30e08c79ed46 |
| institution | Kabale University |
| issn | 2772-9060 |
| language | English |
| publishDate | 2024-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Oral Oncology Reports |
| spelling | doaj-art-ac8645d7b77c4a01b64d30e08c79ed462025-01-09T06:15:46ZengElsevierOral Oncology Reports2772-90602024-06-0110100310Panoptosis – new frontier in research in head neck cancerShrikant B. Mali0Associate professor Oral and Maxillofacial Surgery, Mahatma Gandhi Vidya Mandir's Dental College and Hospital, Nashik, IndiaHead and neck squamous cell carcinoma (HNSCC) is a common cancer that can develop resistance to therapeutic approaches, including chemotherapy, targeted therapy, and immunotherapy. PANoptosis, a non-apoptotic cell death mechanism, has been identified as a potential solution. PANoptosis is a highly coordinated and dynamically balanced programmed inflammatory cell death pathway that combines the main features of pyroptosis, apoptosis, and necroptosis. It has been linked to the development of multiple systemic diseases in the human body, including infectious diseases, cancer, neurodegenerative diseases, and inflammatory diseases. The innate immune system provides the first line of defense against cellular perturbations, and inflammatory programmed cell death is elicited in response to microbial infections or alterations in cellular homeostasis. Programmed cell death (PCD) is a key mechanism for studying anticancer drugs and has a significant impact on the development and management of cancer. Recent research has revealed the existence of the distinct inflammatory PCD modality known as PANoptosis, which is controlled by complex PANoptosome complexes built by combining elements from different PCD pathways. No single PCD route is sufficient to explain all of the physiologic effects seen in PANoptosis. Numerous studies have demonstrated that PANoptosis can successfully stop cancer cells from growing, proliferating, and developing drug resistance, changing the focus of targeted anticancer therapy.http://www.sciencedirect.com/science/article/pii/S2772906024001560Head neck cancerPanoptosisCancerApoptosisPyroptosisNecroptosis |
| spellingShingle | Shrikant B. Mali Panoptosis – new frontier in research in head neck cancer Oral Oncology Reports Head neck cancer Panoptosis Cancer Apoptosis Pyroptosis Necroptosis |
| title | Panoptosis – new frontier in research in head neck cancer |
| title_full | Panoptosis – new frontier in research in head neck cancer |
| title_fullStr | Panoptosis – new frontier in research in head neck cancer |
| title_full_unstemmed | Panoptosis – new frontier in research in head neck cancer |
| title_short | Panoptosis – new frontier in research in head neck cancer |
| title_sort | panoptosis new frontier in research in head neck cancer |
| topic | Head neck cancer Panoptosis Cancer Apoptosis Pyroptosis Necroptosis |
| url | http://www.sciencedirect.com/science/article/pii/S2772906024001560 |
| work_keys_str_mv | AT shrikantbmali panoptosisnewfrontierinresearchinheadneckcancer |